project id: TCGA-PRAD; case submitter id: TCGA-G9-6347; source center: 23; state: released; a260 a280 ratio: 1.85; age at index: 59; days to birth: -21721; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1949; age at diagnosis: 21721; ajcc clinical m: M0; ajcc clinical t: T1c; ajcc pathologic t: T2c; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2089.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 3; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 36.0; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.1; portion submitter id: TCGA-G9-6347-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 0.0; percent tumor cells: 70.0; percent tumor nuclei: 60.0;